Rheumatoid Arthritis-patient reported outcomes (RA-PRO) study for treatment strategies after methotrexate inadequate-response (MTX-IR)
RA-PRO is a 12-month, 2-arm, open-label, RCT pragmatic study to test whether adding TNF-biologic strategy is superior to the alternative approach of small molecule Jak-kinase inhibitor in RA patients with active disease despite adequate trial of methotrexate, i.e. MTX-inadequate responder (IR), in a variety of clinical care settings across the U.S. at multiple sites.
Rheumatology Services | NYU Langone Health
Doctors at NYU Langone Orthopedic Center specialize in arthritis and diseases related to joints, soft tissue, and autoimmunity.
Rimegepant for the treatment of migraine (with or without aura) in children and adolescents
The main purpose of this study is to learn how well the study drug works and how safe the study drug is in children and young people compared with placebo. A placebo is an inactive material that looks like the study drug but does not contain any active study drug. Researchers use a placebo to see if the study drug works better or is safer than taking nothing.
Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction - JUPITER 4.0
The purpose of this research study is to evaluate the outcomes of medial patellofemoral ligament (MPFL) reconstruction for treatment of recurrent patellofemoral instability, in order to determine clear indications and avoid complications where possible.
Risk factors for sudden unexplained death in epilepsy (SUDEP)
The purpose of this multi-site study is to build a research registry – the “North American SUDEP Registry (NASR)” to assess the risk factors and pathophysiologic mechanisms leading to sudden, unexpected death in epilepsy patients (SUDEP). The registry will collect bio-specimens, and medical, lifestyle and where applicable, death information from three cohorts; 1) decedents with or without a history of seizures; 2) living controls with a diagnosis of epilepsy; and 3) immediate family members of a decedent enrolled in NASR who died from SUDEP. The data collected will then be analyzed to investigate the clinical, genetic, and physiological mechanisms and risk factors for SUDEP.
Risks & Benefits of Weight Loss Surgery | NYU Langone Health
At NYU Langone’s Weight Management Program, we educate patients on the most common risks and benefits of bariatric surgery for weight loss.
Roadster 3
The purpose of this research study is intended to evaluate real world usage of the ENROUTE® Transcarotid Stent when used with the ENROUTE® Transcarotid Neuroprotection System for the treatment of carotid artery disease in patients at standard risk for adverse events from carotid endarterectomy (CEA), and the information collected in this study will be used for this purpose. It may also be used in reports of the study or for scientific presentations. The sponsor may also use the information from this study for future medical research, which may be performed by the sponsor together with other companies or researchers
Robert I. Grossman, MD | NYU Langone Health
Dr. Robert I. Grossman is dean and CEO of NYU Langone Health.
Robotic-Assisted Surgery for Ureteral Stricture | NYU Langone Health
NYU Langone urologic surgeons have pioneered robotic-assisted surgery to correct ureteral stricture.
Robotic Mitral Valve Repair for Mitral Valve Disease | NYU Langone Health
NYU Langone cardiothoracic surgeons use robotic mitral valve repair to repair damaged mitral valves.